Psoriasis 2012
DOI: 10.5772/27027
|View full text |Cite
|
Sign up to set email alerts
|

Topical Therapies for Psoriasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(9 citation statements)
references
References 72 publications
0
9
0
Order By: Relevance
“…Tar-based formulations are indicated for the management of chronic, stable forms of plaque-type psoriasis and scalp psoriasis, whereas their use might be limited in sensitive areas such as around the genitals due to their irritation potential [87]. The choice of management strategy for psoriasis is driven by the skin's dryness and itchiness; inflammation and redness; scaliness and thickness [6,35,45,86,87,91,99].…”
Section: Tar-based Activesmentioning
confidence: 99%
See 3 more Smart Citations
“…Tar-based formulations are indicated for the management of chronic, stable forms of plaque-type psoriasis and scalp psoriasis, whereas their use might be limited in sensitive areas such as around the genitals due to their irritation potential [87]. The choice of management strategy for psoriasis is driven by the skin's dryness and itchiness; inflammation and redness; scaliness and thickness [6,35,45,86,87,91,99].…”
Section: Tar-based Activesmentioning
confidence: 99%
“…Keratolytics (Figure 4) such as salicylic acid are readily used as active ingredients in many topical formulations, but may have particular utility when it comes to psoriasis as the disease is characterised by a build-up of keratinocytes on the skin. Keratolytics promote the physiologic skin shedding process and also decrease cell-tocell cohesion in the SC, in effect loosening the glue that keeps keratinocytes together [87,99]. Salicylic acid has been shown to aid in the removal of excessive keratin in psoriatic plaques and to produce desquamation of the SC while being safe to use and not effecting qualitative or quantitative changes in the structure of the viable epidermis [100].…”
Section: Keratolyticsmentioning
confidence: 99%
See 2 more Smart Citations
“…Thus, newer topical formulations should have improved drug-delivery mechanisms with appropriate cosmetic elegance which can be used on many areas of the body including hair-bearing sites to ensure therapeutic efficacy and improved adherence. [ 8 ] Liposomes, microemulsions, solid lipid nanoparticles, nanostructured lipid carriers, and micelles may have the potential to encapsulate antipsoriatic drugs for topical application. In addition, techniques such as iontophoresis, electroporation, and lasers can be used to enhance penetration of the stratum corneum.…”
mentioning
confidence: 99%